Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Dec;110(12):1239–1245. doi: 10.1289/ehp.021101239

DDT and its metabolites alter gene expression in human uterine cell lines through estrogen receptor-independent mechanisms.

Daniel E Frigo 1, Matthew E Burow 1, Kamron A Mitchell 1, Tung-Chin Chiang 1, John A McLachlan 1
PMCID: PMC1241112  PMID: 12460804

Abstract

Endocrine-disrupting organochlorines, such as the pesticide dichlorodiphenyltrichloroethane (DDT), bind to and activate estrogen receptors (ERs), thereby eliciting estrogen-like effects. Although ERs function predominantly through activation of transcription via estrogen-responsive elements, both ERs, alpha and ss, can interact with various transcription factors such as activator protein-1 (AP-1). Additionally, estrogens may regulate early signaling events, suggesting that the biological effects of environmental estrogens may not be mediated through classic ER (alpha and ss) activity alone. We hypothesized that known environmental estrogens, such as DDT and its metabolites, activate AP-1-mediated gene transactivation through both ER-dependent and ER-independent means. Using two Ishikawa human endometrial adenocarcinoma cell line variants that we confirmed to be estrogen responsive [Ishikawa(+)] and estrogen unresponsive [Ishikawa(-)], we generated stably transfected AP-1 luciferase cell lines to identify the role of an estrogen-responsive mechanism in AP-1-mediated gene expression by various stimuli. Our results demonstrate that DDT and dichlorodiphenyldichloroethane (DDD) were the most potent activators of AP-1 activity; 2,2-bis(p-chlorophenyl) acetic acid failed to activate. Although stimulated in both Ishikawa(+) and Ishikawa(-) cells by DDT and its congeners, AP-1 activation was more pronounced in the estrogen-unresponsive Ishikawa(-) cells. In addition, DDT, DDD, and dichlorodiphenyldichloroethylene (DDE) could also stimulate AP-1 activity in the estrogen-unresponsive human embryonic kidney 293 cells using a different promoter context. Thus, our data demonstrate that DDT and its metabolites activate the AP-1 transcription factor independent of ER (alpha or ss) status.

Full Text

The Full Text of this article is available as a PDF (601.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlborg U. G., Lipworth L., Titus-Ernstoff L., Hsieh C. C., Hanberg A., Baron J., Trichopoulos D., Adami H. O. Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol. 1995;25(6):463–531. doi: 10.3109/10408449509017924. [DOI] [PubMed] [Google Scholar]
  2. Alam J. Multiple elements within the 5' distal enhancer of the mouse heme oxygenase-1 gene mediate induction by heavy metals. J Biol Chem. 1994 Oct 7;269(40):25049–25056. [PubMed] [Google Scholar]
  3. Bagchi D., Bagchi M., Tang L., Stohs S. J. Comparative in vitro and in vivo protein kinase C activation by selected pesticides and transition metal salts. Toxicol Lett. 1997 Mar 14;91(1):31–37. doi: 10.1016/s0378-4274(97)03868-x. [DOI] [PubMed] [Google Scholar]
  4. Barrón S., Serratosa J., Tusell J. M. Regulation of c-fos expression by convulsants and hexachlorocyclohexane isomers in primary cultures of cortical neurons. J Neurochem. 1995 Apr;64(4):1708–1714. doi: 10.1046/j.1471-4159.1995.64041708.x. [DOI] [PubMed] [Google Scholar]
  5. Beard J., Marshall S., Jong K., Newton R., Triplett-McBride T., Humphries B., Bronks R. 1,1,1-trichloro-2,2-bis (p-chlorophenyl)-ethane (DDT) and reduced bone mineral density. Arch Environ Health. 2000 May-Jun;55(3):177–180. doi: 10.1080/00039890009603403. [DOI] [PubMed] [Google Scholar]
  6. Boettger-Tong H. L., Murthy L., Stancel G. M. Cellular pattern of c-fos induction by estradiol in the immature rat uterus. Biol Reprod. 1995 Dec;53(6):1398–1406. doi: 10.1095/biolreprod53.6.1398. [DOI] [PubMed] [Google Scholar]
  7. Brown J. R., Nigh E., Lee R. J., Ye H., Thompson M. A., Saudou F., Pestell R. G., Greenberg M. E. Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol. 1998 Sep;18(9):5609–5619. doi: 10.1128/mcb.18.9.5609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burow M. E., Boue S. M., Collins-Burow B. M., Melnik L. I., Duong B. N., Carter-Wientjes C. H., Li S., Wiese T. E., Cleveland T. E., McLachlan J. A. Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta. J Clin Endocrinol Metab. 2001 Apr;86(4):1750–1758. doi: 10.1210/jcem.86.4.7430. [DOI] [PubMed] [Google Scholar]
  9. Burow M. E., Tang Y., Collins-Burow B. M., Krajewski S., Reed J. C., McLachlan J. A., Beckman B. S. Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells. Carcinogenesis. 1999 Nov;20(11):2057–2061. doi: 10.1093/carcin/20.11.2057. [DOI] [PubMed] [Google Scholar]
  10. Burow M. E., Weldon C. B., Chiang T. C., Tang Y., Collins-Burow B. M., Rolfe K., Li S., McLachlan J. A., Beckman B. S. Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. Int J Oncol. 2000 Jun;16(6):1179–1187. doi: 10.3892/ijo.16.6.1179. [DOI] [PubMed] [Google Scholar]
  11. Burow M. E., Weldon C. B., Collins-Burow B. M., Ramsey N., McKee A., Klippel A., McLachlan J. A., Clejan S., Beckman B. S. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J Biol Chem. 2000 Mar 31;275(13):9628–9635. doi: 10.1074/jbc.275.13.9628. [DOI] [PubMed] [Google Scholar]
  12. Caldwell J. D., O'Rourke S. T., Morris M., Walker C. H., Carr R. B., Faggin B. M., Mason G. A. Steroid effects at the membrane level on oxytocin systems. Ann N Y Acad Sci. 1997 Apr 24;814:282–286. doi: 10.1111/j.1749-6632.1997.tb46164.x. [DOI] [PubMed] [Google Scholar]
  13. Campbell R. A., Bhat-Nakshatri P., Patel N. M., Constantinidou D., Ali S., Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem. 2001 Jan 3;276(13):9817–9824. doi: 10.1074/jbc.M010840200. [DOI] [PubMed] [Google Scholar]
  14. Cerillo G., Rees A., Manchanda N., Reilly C., Brogan I., White A., Needham M. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner. J Steroid Biochem Mol Biol. 1998 Oct;67(2):79–88. doi: 10.1016/s0960-0760(98)00078-8. [DOI] [PubMed] [Google Scholar]
  15. Chuang L. F., Chuang R. Y. Heptachlor and the mitogen-activated protein kinase module in human lymphocytes. Toxicology. 1998 Jun 26;128(1):17–23. doi: 10.1016/s0300-483x(98)00042-0. [DOI] [PubMed] [Google Scholar]
  16. Cocco P., Kazerouni N., Zahm S. H. Cancer mortality and environmental exposure to DDE in the United States. Environ Health Perspect. 2000 Jan;108(1):1–4. doi: 10.1289/ehp.001081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Collins-Burow B. M., Burow M. E., Duong B. N., McLachlan J. A. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms. Nutr Cancer. 2000;38(2):229–244. doi: 10.1207/S15327914NC382_13. [DOI] [PubMed] [Google Scholar]
  18. Crews D., Willingham E., Skipper J. K. Endocrine disruptors: present issues, future directions. Q Rev Biol. 2000 Sep;75(3):243–260. doi: 10.1086/393498. [DOI] [PubMed] [Google Scholar]
  19. Das S. K., Tan J., Johnson D. C., Dey S. K. Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen, and xenoestrogen. Endocrinology. 1998 Jun;139(6):2905–2915. doi: 10.1210/endo.139.6.6051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Das S. K., Taylor J. A., Korach K. S., Paria B. C., Dey S. K., Lubahn D. B. Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12786–12791. doi: 10.1073/pnas.94.24.12786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Devanesan P., Santen R. J., Bocchinfuso W. P., Korach K. S., Rogan E. G., Cavalieri E. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors. Carcinogenesis. 2001 Sep;22(9):1573–1576. doi: 10.1093/carcin/22.9.1573. [DOI] [PubMed] [Google Scholar]
  22. Diel P., Schulz T., Smolnikar K., Strunck E., Vollmer G., Michna H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. J Steroid Biochem Mol Biol. 2000 May;73(1-2):1–10. doi: 10.1016/s0960-0760(00)00051-0. [DOI] [PubMed] [Google Scholar]
  23. Duan R., Porter W., Safe S. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology. 1998 Apr;139(4):1981–1990. doi: 10.1210/endo.139.4.5870. [DOI] [PubMed] [Google Scholar]
  24. Duan R., Xie W., Burghardt R. C., Safe S. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J Biol Chem. 2001 Jan 5;276(15):11590–11598. doi: 10.1074/jbc.M005492200. [DOI] [PubMed] [Google Scholar]
  25. Enan E., Matsumura F. Activation of c-Neu tyrosine kinase by o,p'-DDT and beta-HCH in cell-free and intact cell preparations from MCF-7 human breast cancer cells. J Biochem Mol Toxicol. 1998;12(2):83–92. doi: 10.1002/(sici)1099-0461(1998)12:2<83::aid-jbt3>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  26. Filardo E. J., Quinn J. A., Bland K. I., Frackelton A. R., Jr Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000 Oct;14(10):1649–1660. doi: 10.1210/mend.14.10.0532. [DOI] [PubMed] [Google Scholar]
  27. Flanagan L., Van Weelden K., Ammerman C., Ethier S. P., Welsh J. SUM-159PT cells: a novel estrogen independent human breast cancer model system. Breast Cancer Res Treat. 1999 Dec;58(3):193–204. doi: 10.1023/a:1006331716981. [DOI] [PubMed] [Google Scholar]
  28. Fry D. M., Toone C. K. DDT-induced feminization of gull embryos. Science. 1981 Aug 21;213(4510):922–924. doi: 10.1126/science.7256288. [DOI] [PubMed] [Google Scholar]
  29. Galán A., Garcia-Bermejo L., Vilaboa N. E., de Blas E., Aller P. Uncoupling of apoptosis and Jun/AP-1 activity in human promonocytic cells treated with DNA-damaging and stress-inducing agents. Eur J Cell Biol. 2000 Jan;79(1):1–9. doi: 10.1078/S0171-9335(04)70001-1. [DOI] [PubMed] [Google Scholar]
  30. Ghosh D., Taylor J. A., Green J. A., Lubahn D. B. Methoxychlor stimulates estrogen-responsive messenger ribonucleic acids in mouse uterus through a non-estrogen receptor (non-ER) alpha and non-ER beta mechanism. Endocrinology. 1999 Aug;140(8):3526–3533. doi: 10.1210/endo.140.8.6877. [DOI] [PubMed] [Google Scholar]
  31. Giordano A., Avantaggiati M. L. p300 and CBP: partners for life and death. J Cell Physiol. 1999 Nov;181(2):218–230. doi: 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  32. Guillette L. J., Jr, Gross T. S., Masson G. R., Matter J. M., Percival H. F., Woodward A. R. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect. 1994 Aug;102(8):680–688. doi: 10.1289/ehp.94102680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Guillette L. J., Jr, Woodward A. R., Crain D. A., Pickford D. B., Rooney A. A., Percival H. F. Plasma steroid concentrations and male phallus size in juvenile alligators from seven Florida lakes. Gen Comp Endocrinol. 1999 Dec;116(3):356–372. doi: 10.1006/gcen.1999.7375. [DOI] [PubMed] [Google Scholar]
  34. Gulledge C. C., Burow M. E., McLachlan J. A. Endocrine disruption in sexual differentiation and puberty. What do pseudohermaphroditic polar bears have to do with the practice of pediatrics? Pediatr Clin North Am. 2001 Oct;48(5):1223-40, x. doi: 10.1016/s0031-3955(05)70371-0. [DOI] [PubMed] [Google Scholar]
  35. Hague F., Matifat F., Louvet L., Brûle G., Collin T. The carcinogen Cd(2+) activates InsP(3)-mediated Ca(2+) release through a specific metal ion receptor in Xenopus oocyte. Cell Signal. 2000 Jun;12(6):419–424. doi: 10.1016/s0898-6568(00)00079-6. [DOI] [PubMed] [Google Scholar]
  36. Hall J. M., McDonnell D. P. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999 Dec;140(12):5566–5578. doi: 10.1210/endo.140.12.7179. [DOI] [PubMed] [Google Scholar]
  37. Hatakeyama M., Matsumura F. Correlation between the activation of Neu tyrosine kinase and promotion of foci formation induced by selected organochlorine compounds in the MCF-7 model system. J Biochem Mol Toxicol. 1999;13(6):296–302. doi: 10.1002/(sici)1099-0461(1999)13:6<296::aid-jbt2>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  38. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 1993 Nov;7(11):2135–2148. doi: 10.1101/gad.7.11.2135. [DOI] [PubMed] [Google Scholar]
  39. Hruska K. S., Furth P. A., Seifer D. B., Sharara F. I., Flaws J. A. Environmental factors in infertility. Clin Obstet Gynecol. 2000 Dec;43(4):821–829. doi: 10.1097/00003081-200012000-00014. [DOI] [PubMed] [Google Scholar]
  40. Hsu T. C., Young M. R., Cmarik J., Colburn N. H. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med. 2000 May 1;28(9):1338–1348. doi: 10.1016/s0891-5849(00)00220-3. [DOI] [PubMed] [Google Scholar]
  41. Huang C., Ma W. Y., Young M. R., Colburn N., Dong Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):156–161. doi: 10.1073/pnas.95.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ignar-Trowbridge D. M., Nelson K. G., Bidwell M. C., Curtis S. W., Washburn T. F., McLachlan J. A., Korach K. S. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4658–4662. doi: 10.1073/pnas.89.10.4658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ignar-Trowbridge D. M., Pimentel M., Parker M. G., McLachlan J. A., Korach K. S. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology. 1996 May;137(5):1735–1744. doi: 10.1210/endo.137.5.8612509. [DOI] [PubMed] [Google Scholar]
  44. Iguchi T., Fukazawa Y., Bern H. A. Effects of sex hormones on oncogene expression in the vagina and on development of sexual dimorphism of the pelvis and anococcygeus muscle in the mouse. Environ Health Perspect. 1995 Oct;103 (Suppl 7):79–82. doi: 10.1289/ehp.95103s779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Improta-Brears T., Whorton A. R., Codazzi F., York J. D., Meyer T., McDonnell D. P. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4686–4691. doi: 10.1073/pnas.96.8.4686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Jaga K. What are the implications of the interaction between DDT and estrogen receptors in the body? Med Hypotheses. 2000 Jan;54(1):18–25. doi: 10.1054/mehy.1998.0811. [DOI] [PubMed] [Google Scholar]
  47. Jenster G. Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines. J Pathol. 2000 Jul;191(3):227–228. doi: 10.1002/1096-9896(200007)191:3<227::AID-PATH636>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  48. Kelly M. J., Levin E. R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab. 2001 May-Jun;12(4):152–156. doi: 10.1016/s1043-2760(01)00377-0. [DOI] [PubMed] [Google Scholar]
  49. Klotz D. M., Beckman B. S., Hill S. M., McLachlan J. A., Walters M. R., Arnold S. F. Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environ Health Perspect. 1996 Oct;104(10):1084–1089. doi: 10.1289/ehp.961041084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Korrick S. A., Chen C., Damokosh A. I., Ni J., Liu X., Cho S. I., Altshul L., Ryan L., Xu X. Association of DDT with spontaneous abortion: a case-control study. Ann Epidemiol. 2001 Oct;11(7):491–496. doi: 10.1016/s1047-2797(01)00239-3. [DOI] [PubMed] [Google Scholar]
  51. Kuiper G. G., Lemmen J. G., Carlsson B., Corton J. C., Safe S. H., van der Saag P. T., van der Burg B., Gustafsson J. A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998 Oct;139(10):4252–4263. doi: 10.1210/endo.139.10.6216. [DOI] [PubMed] [Google Scholar]
  52. Kupfer D., Bulger W. H. Interactions of chlorinated hydrocarbons with steroid hormones. Fed Proc. 1976 Dec;35(14):2603–2608. [PubMed] [Google Scholar]
  53. Kushner P. J., Agard D. A., Greene G. L., Scanlan T. S., Shiau A. K., Uht R. M., Webb P. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):311–317. doi: 10.1016/s0960-0760(00)00108-4. [DOI] [PubMed] [Google Scholar]
  54. Lee S. K., Kim J. H., Lee Y. C., Cheong J., Lee J. W. Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor. J Biol Chem. 2000 Apr 28;275(17):12470–12474. doi: 10.1074/jbc.275.17.12470. [DOI] [PubMed] [Google Scholar]
  55. Li X. R., Chong A. S., Wu J., Roebuck K. A., Kumar A., Parrillo J. E., Rapp U. R., Kimberly R. P., Williams J. W., Xu X. Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T cell antigen receptor.CD3 complex-stimulated T cells. J Biol Chem. 1999 Dec 3;274(49):35203–35210. doi: 10.1074/jbc.274.49.35203. [DOI] [PubMed] [Google Scholar]
  56. MacGregor Schafer J., Liu H., Levenson A. S., Horiguchi J., Chen Z., Jordan V. C. Estrogen receptor alpha mediated induction of the transforming growth factor alpha gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cells. J Steroid Biochem Mol Biol. 2001 Jul;78(1):41–50. doi: 10.1016/s0960-0760(01)00072-3. [DOI] [PubMed] [Google Scholar]
  57. Martin M. B., Franke T. F., Stoica G. E., Chambon P., Katzenellenbogen B. S., Stoica B. A., McLemore M. S., Olivo S. E., Stoica A. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology. 2000 Dec;141(12):4503–4511. doi: 10.1210/endo.141.12.7836. [DOI] [PubMed] [Google Scholar]
  58. Matthews J., Celius T., Halgren R., Zacharewski T. Differential estrogen receptor binding of estrogenic substances: a species comparison. J Steroid Biochem Mol Biol. 2000 Nov 15;74(4):223–234. doi: 10.1016/s0960-0760(00)00126-6. [DOI] [PubMed] [Google Scholar]
  59. McInerney E. M., Weis K. E., Sun J., Mosselman S., Katzenellenbogen B. S. Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras. Endocrinology. 1998 Nov;139(11):4513–4522. doi: 10.1210/endo.139.11.6298. [DOI] [PubMed] [Google Scholar]
  60. Metz R., Kouzarides T., Bravo R. A C-terminal domain in FosB, absent in FosB/SF and Fra-1, which is able to interact with the TATA binding protein, is required for altered cell growth. EMBO J. 1994 Aug 15;13(16):3832–3842. doi: 10.1002/j.1460-2075.1994.tb06694.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Mitra J., Raghu K. Long-term DDT pollution in tropical soils: effect of DDT and degradation products on soil microbial activities leading to soil fertility. Bull Environ Contam Toxicol. 1998 Apr;60(4):585–591. doi: 10.1007/s001289900665. [DOI] [PubMed] [Google Scholar]
  62. Mousa M. A., Ganey P. E., Quensen J. F., 3rd, Madhukar B. V., Chou K., Giesy J. P., Fischer L. J., Boyd S. A. Altered biologic activities of commercial polychlorinated biphenyl mixtures after microbial reductive dechlorination. Environ Health Perspect. 1998 Dec;106 (Suppl 6):1409–1418. doi: 10.1289/ehp.98106s61409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Muramatsu M., Inoue S. Estrogen receptors: how do they control reproductive and nonreproductive functions? Biochem Biophys Res Commun. 2000 Apr 2;270(1):1–10. doi: 10.1006/bbrc.2000.2214. [DOI] [PubMed] [Google Scholar]
  64. Mäkelä S., Santti R., Salo L., McLachlan J. A. Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ Health Perspect. 1995 Oct;103 (Suppl 7):123–127. doi: 10.1289/ehp.103-1518873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Nadal A., Ropero A. B., Laribi O., Maillet M., Fuentes E., Soria B. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11603–11608. doi: 10.1073/pnas.97.21.11603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Paech K., Webb P., Kuiper G. G., Nilsson S., Gustafsson J., Kushner P. J., Scanlan T. S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 1997 Sep 5;277(5331):1508–1510. doi: 10.1126/science.277.5331.1508. [DOI] [PubMed] [Google Scholar]
  67. Peverali F. A., Basdra E. K., Papavassiliou A. G. Stretch-mediated activation of selective MAPK subtypes and potentiation of AP-1 binding in human osteoblastic cells. Mol Med. 2001 Jan;7(1):68–78. [PMC free article] [PubMed] [Google Scholar]
  68. Provini A., Galassi S. Polychlorinated biphenyls and chlorinated pesticides in bird eggs from Calabria (southern Italy). Ecotoxicol Environ Saf. 1999 May;43(1):91–97. doi: 10.1006/eesa.1999.1772. [DOI] [PubMed] [Google Scholar]
  69. Ramamoorthy K., Vyhlidal C., Wang F., Chen I., Safe S., McDonnell D. P., Leonard L. S., Gaido K. W. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol. Toxicol Appl Pharmacol. 1997 Nov;147(1):93–100. doi: 10.1006/taap.1997.8281. [DOI] [PubMed] [Google Scholar]
  70. Rier S. E., Martin D. C., Bowman R. E., Dmowski W. P., Becker J. L. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1993 Nov;21(4):433–441. doi: 10.1006/faat.1993.1119. [DOI] [PubMed] [Google Scholar]
  71. Ruehlmann D. O., Steinert J. R., Valverde M. A., Jacob R., Mann G. E. Environmental estrogenic pollutants induce acute vascular relaxation by inhibiting L-type Ca2+ channels in smooth muscle cells. FASEB J. 1998 May;12(7):613–619. doi: 10.1096/fasebj.12.7.613. [DOI] [PubMed] [Google Scholar]
  72. Safe S. H., Zacharewski T. Organochlorine exposure and risk for breast cancer. Prog Clin Biol Res. 1997;396:133–145. [PubMed] [Google Scholar]
  73. Sawai H., Okazaki T., Yamamoto H., Okano H., Takeda Y., Tashima M., Sawada H., Okuma M., Ishikura H., Umehara H. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem. 1995 Nov 10;270(45):27326–27331. doi: 10.1074/jbc.270.45.27326. [DOI] [PubMed] [Google Scholar]
  74. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000 Oct 13;103(2):211–225. doi: 10.1016/s0092-8674(00)00114-8. [DOI] [PubMed] [Google Scholar]
  75. Schnell N., Krems B., Entian K. D. The PAR1 (YAP1/SNQ3) gene of Saccharomyces cerevisiae, a c-jun homologue, is involved in oxygen metabolism. Curr Genet. 1992 Apr;21(4-5):269–273. doi: 10.1007/BF00351681. [DOI] [PubMed] [Google Scholar]
  76. Shekhar P. V., Werdell J., Basrur V. S. Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human breast cell lines. J Natl Cancer Inst. 1997 Dec 3;89(23):1774–1782. doi: 10.1093/jnci/89.23.1774. [DOI] [PubMed] [Google Scholar]
  77. Shen K., Novak R. F. DDT stimulates c-erbB2, c-met, and STATS tyrosine phosphorylation, Grb2-Sos association, MAPK phosphorylation, and proliferation of human breast epithelial cells. Biochem Biophys Res Commun. 1997 Feb 3;231(1):17–21. doi: 10.1006/bbrc.1996.6039. [DOI] [PubMed] [Google Scholar]
  78. Shen K., Novak R. F. Differential effects of aroclors and DDT on growth factor gene expression and receptor tyrosine kinase activity in human breast epithelial cells. Adv Exp Med Biol. 1997;407:295–302. doi: 10.1007/978-1-4899-1813-0_44. [DOI] [PubMed] [Google Scholar]
  79. Shi H., Teng C. T. Characterization of a mitogen-response unit in the mouse lactoferrin gene promoter. J Biol Chem. 1994 Apr 29;269(17):12973–12980. [PubMed] [Google Scholar]
  80. Shi H., Teng C. Promoter-specific activation of mouse lactoferrin gene by epidermal growth factor involves two adjacent regulatory elements. Mol Endocrinol. 1996 Jun;10(6):732–741. doi: 10.1210/mend.10.6.8776733. [DOI] [PubMed] [Google Scholar]
  81. Shukla G. S., Shukla A., Potts R. J., Osier M., Hart B. A., Chiu J. F. Cadmium-mediated oxidative stress in alveolar epithelial cells induces the expression of gamma-glutamylcysteine synthetase catalytic subunit and glutathione S-transferase alpha and pi isoforms: potential role of activator protein-1. Cell Biol Toxicol. 2000;16(6):347–362. doi: 10.1023/a:1007696610186. [DOI] [PubMed] [Google Scholar]
  82. Skakkebaek N. E., Rajpert-De Meyts E., Jørgensen N., Carlsen E., Petersen P. M., Giwercman A., Andersen A. G., Jensen T. K., Andersson A. M., Müller J. Germ cell cancer and disorders of spermatogenesis: an environmental connection? APMIS. 1998 Jan;106(1):3–12. doi: 10.1111/j.1699-0463.1998.tb01314.x. [DOI] [PubMed] [Google Scholar]
  83. Stoica A., Katzenellenbogen B. S., Martin M. B. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol. 2000 Apr;14(4):545–553. doi: 10.1210/mend.14.4.0441. [DOI] [PubMed] [Google Scholar]
  84. Strunck E., Stemmann N., Hopert A., Wünsche W., Frank K., Vollmer G. Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol. 2000 Oct;74(3):73–81. doi: 10.1016/s0960-0760(00)00092-3. [DOI] [PubMed] [Google Scholar]
  85. Sundlof S. F., Forrester D. J., Thompson N. P., Collopy M. W. Residues of chlorinated hydrocarbons in tissues of raptors in Florida. J Wildl Dis. 1986 Jan;22(1):71–82. doi: 10.7589/0090-3558-22.1.71. [DOI] [PubMed] [Google Scholar]
  86. Tessier D. M., Matsumura F. Increased ErbB-2 tyrosine kinase activity, MAPK phosphorylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicol Sci. 2001 Mar;60(1):38–43. doi: 10.1093/toxsci/60.1.38. [DOI] [PubMed] [Google Scholar]
  87. Thompson E. W., Paik S., Brünner N., Sommers C. L., Zugmaier G., Clarke R., Shima T. B., Torri J., Donahue S., Lippman M. E. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol. 1992 Mar;150(3):534–544. doi: 10.1002/jcp.1041500314. [DOI] [PubMed] [Google Scholar]
  88. Tyler C. R., Jobling S., Sumpter J. P. Endocrine disruption in wildlife: a critical review of the evidence. Crit Rev Toxicol. 1998 Jul;28(4):319–361. doi: 10.1080/10408449891344236. [DOI] [PubMed] [Google Scholar]
  89. Tyulmenkov V. V., Jernigan S. C., Klinge C. M. Comparison of transcriptional synergy of estrogen receptors alpha and beta from multiple tandem estrogen response elements. Mol Cell Endocrinol. 2000 Jul 25;165(1-2):151–161. doi: 10.1016/s0303-7207(00)00250-1. [DOI] [PubMed] [Google Scholar]
  90. Tyulmenkov V. V., Klinge C. M. Estrogen receptors alpha and beta exhibit different estradiol and estrogen response element binding in the presence of nonspecific DNA. Arch Biochem Biophys. 2001 Jun 15;390(2):253–264. doi: 10.1006/abbi.2001.2382. [DOI] [PubMed] [Google Scholar]
  91. Vandelac L., Bacon M. H. Will we be taught ethics by our clones? The mutations of the living, from endocrine disruptors to genetics. Baillieres Best Pract Res Clin Obstet Gynaecol. 1999 Dec;13(4):571–592. doi: 10.1053/beog.1999.0050. [DOI] [PubMed] [Google Scholar]
  92. Wang Q., Ji Y., Wang X., Evers B. M. Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene. Biochem Biophys Res Commun. 2000 Sep 24;276(2):466–471. doi: 10.1006/bbrc.2000.3512. [DOI] [PubMed] [Google Scholar]
  93. Webb P., Nguyen P., Valentine C., Lopez G. N., Kwok G. R., McInerney E., Katzenellenbogen B. S., Enmark E., Gustafsson J. A., Nilsson S. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol. 1999 Oct;13(10):1672–1685. doi: 10.1210/mend.13.10.0357. [DOI] [PubMed] [Google Scholar]
  94. Willingham E., Crews D. Sex reversal effects of environmentally relevant xenobiotic concentrations on the red-eared slider turtle, a species with temperature-dependent sex determination. Gen Comp Endocrinol. 1999 Mar;113(3):429–435. doi: 10.1006/gcen.1998.7221. [DOI] [PubMed] [Google Scholar]
  95. Wisdom R. AP-1: one switch for many signals. Exp Cell Res. 1999 Nov 25;253(1):180–185. doi: 10.1006/excr.1999.4685. [DOI] [PubMed] [Google Scholar]
  96. Wisdom R., Johnson R. S., Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 1999 Jan 4;18(1):188–197. doi: 10.1093/emboj/18.1.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Wolff M. S., Toniolo P. G., Lee E. W., Rivera M., Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst. 1993 Apr 21;85(8):648–652. doi: 10.1093/jnci/85.8.648. [DOI] [PubMed] [Google Scholar]
  98. Wünsche W., Tenniswood M. P., Schneider M. R., Vollmer G. Estrogenic regulation of clusterin mRNA in normal and malignant endometrial tissue. Int J Cancer. 1998 May 29;76(5):684–688. doi: 10.1002/(sici)1097-0215(19980529)76:5<684::aid-ijc12>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  99. Yoon K., Pallaroni L., Stoner M., Gaido K., Safe S. Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements. J Steroid Biochem Mol Biol. 2001 Jul;78(1):25–32. doi: 10.1016/s0960-0760(01)00070-x. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES